IndraLab

Statements


YAP1 activates JOSD2. 1 / 1
| 1

reach
"Moreover, patient derived cell (PDC) and patient-derived xenograft (PDX) model were further introduced to validate the YAP/TAZ regulation and tumor-promoting roles of JOSD2 in CCA patients."